Publications
4 shownRenoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
The angiotensin-II-receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the re...
The Rising Prevalence of Diabetes and Impaired Glucose Tolerance
OBJECTIVE—To determine the population-based prevalence of diabetes and other categories of glucose intolerance (impaired glucose tolerance [IGT] and impaired fasting glucose [IF...
The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics
The baseline characteristics of the study subjects are: age 59+/-8 years, duration of diabetes 15+/-9 years, height 168+/-11 cm (5 ft 6 in), weight 87+/-19 kg (192 lb), body mas...
Frequent Co-Authors
Researcher Info
- h-index
- 4
- Publications
- 4
- Citations
- 10,934
- Institution
- Monash Medical Centre
External Links
Impact Metrics
h-index
4
h-index: Number of publications with at least h citations each.